Mutant enzymes
US-2015376580-A1 · Dec 31, 2015 · US
US2019352673A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2019352673-A1 |
| Application number | US-201716472120-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 18, 2017 |
| Priority date | Dec 22, 2016 |
| Publication date | Nov 21, 2019 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are methods of producing (+)-manool, the methods including: contacting geranylgeranyl diphosphate with a copalyl diphosphate (CPP) synthase to form a (9S, 10S)-copalyl diphosphate and contacting the CPP with a sclareol synthase enzyme to form (+)-manool and derivatives thereof. Also described herein are nucleic acids encoding CPP synthases and sclareol synthases for use in the methods. Further described herein are expression vectors and non-human host organisms and cells including nucleic acids encoding a CPP synthase and a sclareol synthase as described herein.
Opening claim text (preview).
1 . A method of producing (+)-manool, the method comprising: a) contacting geranylgeranyl diphosphate (GGPP) with a copalyl diphosphate (CPP) synthase to form a copalyl diphosphate, wherein the CPP synthase comprises a) an amino acid sequence having at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or b) an amino acid sequence having at least 71%, 72%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 17 or SEQ ID NO: 18; or c) an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to SEQ ID NO: 20 or SEQ ID NO: 21; and b) contacting the CPP with a sclareol synthase to form the (+)-manool; and c) optionally isolating the (+)-manool. 2 . The method of claim 1 , wherein the CPP synthase comprises a) a polypeptide comprising an amino acid sequence having at least 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or b) a polypeptide comprising an amino acid sequence having at least 90%, 95%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 17 or SEQ ID NO: 18; or c) a polypeptide comprising an amino acid sequence having at least 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 20 or SEQ ID NO: 21. 3 . The method of claim 1 , wherein step a) further comprises culturing a non-human host organism or cell capable of producing GGPP and transformed to express at least one polypeptide comprising a) an amino acid sequence having at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or b) an amino acid sequence having at least 71%, 72%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 17 or SEQ ID NO: 18; or c) an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to SEQ ID NO: 20 or SEQ ID NO: 21; and having a CPP synthase activity, under conditions conducive to a production of CPP. 4 . The method of claim 1 , wherein the method further comprises, prior to step a), transforming a non-human host organism or cell capable of producing GGPP with a) at least one nucleic acid encoding a polypeptide comprising a) an amino acid sequence having at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or b) an amino acid sequence having at least 71%, 72%, 75%, 80%, 85%, 90%, 95%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 17 and SEQ ID NO: 18; or c) an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 20 or SEQ ID NO: 21; and having a CPP synthase activity, so that said organism or cell expresses said polypeptide having a CPP synthase activity; and b) at least one nucleic acid encoding a polypeptide having a sclareol synthase activity, so that said organism or cell expresses said polypeptide having a sclareol synthase activity. 5 . The method as recited in claim 4 , wherein the polypeptide having sclareol synthase activity comprises an amino acid sequence having at least 90%, 95%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 23, or SEQ ID NO: 25. 6 . The method as recited in claim 1 , further comprising processing the (+)-manool to a (+)-manool derivative using a chemical or biochemical synthesis or a combination of both. 7 . The method as recited in claim 6 , wherein the derivative is an alcohol, acetal, aldehyde, acid, ether, ketone, lactone, acetate or an ester. 8 . The method as recited in claim 6 , wherein the derivative is selected from the group consisting of copalol, copalal, manooloxy, Z-11, gamma-ambrol and ambrox. 9 . A method for transforming a host cell or non-human organism, the method comprising transforming a host cell or non-human organism with a nucleic acid encoding a polypeptide having a copalyl diphosphate synthase activity and a nucleic acid encoding a polypeptide having a sclareol synthase activity, wherein the polypeptide having copalyl diphosphate activity comprises a) an amino acid sequence having at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or b) an amino acid sequence having at least 71%, 72%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 17 or SEQ ID NO: 18; or c) an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to SEQ ID NO: 20 and SEQ ID NO: 21; and wherein the polypeptide having sclareol synthase activity comprises an amino acid sequence having at least 90%, 95%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 23, or SEQ ID NO: 25. 10 . The method as recited in claim 4 , wherein the host cell or non-human organism is a plant, a prokaryote, or a fungus. 11 . The method as recited in claim 4 , wherein the non-human host organism or cell is E. coli or Saccharomyces cerevisiae. 12 . An expression vector comprising a) a nucleic acid encoding a polypeptide having a CPP synthase activity comprising a) an amino acid sequence having at least 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or b) an amino acid sequence having at least 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 17 or SEQ ID NO: 18; or c) an amino acid sequence having at 98%, 99% or 100% sequence identity SEQ ID NO: 20 or SEQ ID NO: 21; or b) a nucleic acid encoding a polypeptide having a CPP synthase activity comprising a nucleotide sequence having at least 90%, 95%, 98%, 99% or 100% sequence identity to a nucleic acid sequence as set forth in SEQ ID NO: 13, SEQ ID NO: 16, SEQ ID NO: 19, SEQ ID NO: 22, SEQ ID NO: 26, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, or SEQ ID NO: 32. 13 . The expression vector of claim 12 further comprising a) a nucleic acid encoding a polypeptide having a sclareol synthase activity, wherein the polypeptide having sclareol synthase activity comprises an amino acid sequence having at least 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 23, or SEQ ID NO: 25; or b) a nucleic acid encoding a polypeptide having a sclareol synthase activity comprising a nucleotide sequence having at least 90%, 95%, 98%,99% or 100% sequence identity to SEQ ID NO: 6, SEQ ID NO: 24, SEQ ID NO: 27, SEQ ID NO: 33, or SEQ ID NO: 34. 14 . A non-human host organism or cell comprising a) the expression vector as recited in claim 12 ; or b) a nucleic acid encoding a polypeptide having a copalyl diphosphate synthase activity and a nucleic acid encoding a polypeptide having a sclareol synthase activity, wherein the polypeptide having copalyl diphosphate activity comprises i. an amino acid sequence having at least 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 14 or SEQ ID NO: 15; or ii. an amino acid sequence having at least 71%, 72%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 17 or SEQ ID NO: 18; or iii. an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity to SEQ ID NO: 20 or SEQ ID NO: 21; and wherein the polypeptide having sclareol synthase activity comprises an amino acid sequence having at least 90%, 95%, 98%, 99% or 100% sequence identity to SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 23, or SEQ ID NO: 25; and wherein at least one
Related publications grouped by family.
Answers are generated from the same data shown on this page.